3 CYCLES OF CHEMOTHERAPY FOLLOWED BY PRIMARY CYTOREDUCTIVE SURGERY FOR UNRESECTABLE OVARIAN-CANCER

被引:1
|
作者
GUIDOZZI, F
SONNENDECKER, EWW
机构
关键词
D O I
10.1016/0090-8258(91)90043-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Definitive primary cytoreductive surgery was achieved at second laparotomy after three cycles of combination chemotherapy (cisplatin and cyclophosphamide) in three patients who presented with unresectable disease at our Ovarian Tumor Unit. The ovarian cancer was inoperable at the first laparotomy and no surgical procedure was performed other than biopsy of malignant tumor to confirm the diagnosis. Following interventional surgical cytoreduction the patients were given a further six courses of combination chemotherapy and then maintained for a further six cycles on oral chlorambucil. Two patients are disease free at 17 and 21 months, respectively, while the other patient has cytological evidence of malignancy but no other clinically detectable tumor deposits at 27 months. © 1991.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 50 条
  • [11] Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer
    Ushijima, K
    Ota, S
    Komai, K
    Matsuo, G
    Motoshima, S
    Honda, S
    Tomonari, R
    Sugiyama, T
    Kamura, T
    INTERNATIONAL SURGERY, 2002, 87 (03) : 185 - 190
  • [12] SURGICAL STAGING AND CYTOREDUCTIVE SURGERY OF EPITHELIAL OVARIAN-CANCER
    HOSKINS, WJ
    CANCER, 1993, 71 (04) : 1534 - 1540
  • [13] UROLOGIC OPERATIONS DURING CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER
    BEREK, JS
    HACKER, NF
    LEUCHTER, RS
    LAGASSE, LD
    BYRON, RL
    GYNECOLOGIC ONCOLOGY, 1980, 10 (03) : 365 - 365
  • [14] USE OF APROTININE DURING CYTOREDUCTIVE SURGERY OF OVARIAN-CANCER
    LEQUEAU, F
    BOURGAIN, JL
    CASTAIGNE, D
    SAMAMA, M
    BRITISH JOURNAL OF ANAESTHESIA, 1993, 70 : 50 - 50
  • [15] SECONDARY CYTOREDUCTIVE SURGERY FOR RECURRENT EPITHELIAL OVARIAN-CANCER
    MORRIS, M
    GERSHENSON, DM
    WHARTON, JT
    COPELAND, LJ
    EDWARDS, CL
    STRINGER, CA
    GYNECOLOGIC ONCOLOGY, 1989, 34 (03) : 334 - 338
  • [16] CONTROVERSIAL ASPECTS OF CYTOREDUCTIVE SURGERY IN EPITHELIAL OVARIAN-CANCER
    HACKER, NF
    BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1989, 3 (01): : 49 - 57
  • [17] Primary chemotherapy followed by interval surgery in advanced ovarian cancer
    Huober, J
    Meyer, A
    Wagner, U
    Wallwiener, D
    MEDIZINISCHE WELT, 2001, 52 (04): : 101 - 105
  • [18] PRIMARY CHEMOTHERAPY IN EPITHELIAL OVARIAN-CANCER
    HURWITZ, HI
    MCGUIRE, WP
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1994, 21 (01) : 141 - 154
  • [19] OVARIAN-CANCER WITH METASTATIC DEPOSITS IN THE CERVIX, VAGINA, OR VULVA PRECEDING PRIMARY CYTOREDUCTIVE SURGERY
    GUIDOZZI, F
    SONNENDECKER, EWW
    WRIGHT, C
    GYNECOLOGIC ONCOLOGY, 1993, 49 (02) : 225 - 228
  • [20] Cytoreductive surgery following neoadjuvant chemotherapy in patients with initial unresectable stage IV ovarian cancer
    Hogen, Liat
    Tanen, Adina
    May, Taymaa
    Avery, Lisa
    Ferguson, Sarah
    Laframboise, Stephane
    Bouchard-Fortier, Genevieve
    Bernardini, Marcus
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S132 - S132